sciencenewsnet.in

MOBILION EXPANDS APPLICATIONS FOR MOBIE AND HIGHLIGHTS NEW RESEARCH AT ASMS 2022

CHADDS FORDS, Pa.June 2, 2022 /PRNewswire/ — MOBILion Systems Inc. is teaming up with its industry partners, including Agilent Technologies and Protein Metrics, to deliver a series of educational events at the 70th Annual American Society for Mass Spectrometry (ASMS) conference being held June 5th to June 9th in Minneapolis, Minnesota.

The company debuted MOBIE, the first commercial high-resolution ion mobility (HRIM) instrument based on SLIM* technology, to the ASMS community in November 2021, and is returning to ASMS to highlight additional applications that demonstrate MOBIE’s ability to address characterization challenges, unravel the complexities of biomolecules, and enhance separation science to solve complex analytical challenges.

Dr. Melissa Sherman, CEO, MOBILion Systems, commented: “ASMS is such a pivotal event among the mass spec community. It’s exciting to be collaborating with industry partners and thought leaders to deliver a series of educational workshops and presentations demonstrating how MOBIE advances separation science. ASMS 2022 is set to be a great conference and we are looking forward to updating the industry on our technical and applications development achievements in addition to working with our peers to advocate for improving diversity in our industry.”

Stop by booth #502 to meet the team. For more information about MOBILion Systems at ASMS 2022 and to register for the kickoff event and workshops, please visit MOBILion at ASMS.

* Structures for lossless ion manipulation

About MOBILion Systems, Inc.  
MOBILion Systems Inc. is advancing separation science with the commercialization of High-Resolution Ion Mobility Mass Spec (HRIM-MS) based on Structures for Lossless Ion Manipulation (SLIM). HRIM-MS provides fast, efficient, high-resolution separations to improve the characterization of biopharmaceuticals and accelerate the drug development process. It provides faster, more accurate and more reliable monitoring of critical quality attributes and is proving extremely beneficial for scientists working with complex and challenging analyte classes such as glycans and lipids. HRIM is untangling the complexities of these molecules for biomarker discovery and enabling deeper level characterization than what is possible with incumbent approaches, revealing what others leave unseen.

The company is headquartered in Chadds Ford, Pennsylvania within the Philadelphia biopharmaceutical and medical innovation corridor.